2024-03-29T15:02:31Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_256BFE957857
2024-03-23T02:01:35Z
serval:BIB_256BFE957857
Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
10.1128/AAC.47.8.2487-2491.2003
000184449800016
12878509
Kühn
F.
author
Cottagnoud
M.
author
Acosta
F.
author
Flatz
L.
author
Entenza
J.
author
Cottagnoud
P.
author
article
2003
Antimicrobial Agents and Chemotherapy
0066-4804[print], 0066-4804[linking]
journal
47
8
2487-2491
Animals
Anti-Infective Agents/cerebrospinal fluid
Anti-Infective Agents/pharmacology
Cefotaxime/cerebrospinal fluid
Cefotaxime/pharmacology
Cephalosporins/cerebrospinal fluid
Cephalosporins/pharmacology
DNA, Bacterial/genetics
Drug Resistance, Bacterial
Drug Synergism
Meningitis, Pneumococcal/drug therapy
Meningitis, Pneumococcal/microbiology
Microbial Sensitivity Tests
Mutation/genetics
Ofloxacin/cerebrospinal fluid
Ofloxacin/pharmacology
Penicillin Resistance
Rabbits
Reverse Transcriptase Polymerase Chain Reaction
Streptococcus pneumoniae/drug effects
Streptococcus pneumoniae/genetics
eng
60_published
true